- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT05574218
Effect of a Maintenance Protocol After Surgical Treatment of Peri-implantitis
Effect of a Maintenance Protocol Based on the Surgical Treatment of Peri-implantitis and Implant Surface Decontamination With Glycine Powder Air-polishing
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Detaljert beskrivelse
Study design:
This study was designed as a 12-month, two arms, RCT to evaluate the efficacy of a SPIC protocol. Thirty patients were randomized, six months after access-flap surgery, in two different SPIT groups. After ultrasonic debridement, the affected implant surfaces of the test group were treated with glycine powder air-polishing, while implants in the control group a rubber cup and polishing paste was used. Maintenance visits were carried every 3 months and clinical, radiological, microbiological and biochemical variables were registered at baseline (6 months after surgery) and after a follow-up period of 12 months (18 months after surgery).
Interventions:
At the 6-month evaluation after the surgery, the baseline data for the present study were obtained and patients were randomised using a computerized block randomization protocol to one of the following SPIC protocols. In the test group, implant surfaces were treated with glycine powder air-polishing after ultrasonic instrumentation; the specific nozzle was activated subgingivally and circumferentially around the implant for 1 minute. In the control group, implants were cleaned with a rubber cup and polishing paste after ultrasonic instrumentation. This SPIC visits were carried out at 6 (baseline visit), 9, 12, 15 and 18 months after surgery.
Studietype
Registrering (Faktiske)
Fase
- Ikke aktuelt
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
- Barn
- Voksen
- Eldre voksen
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Presence of at least one implant with peri-implantitis, defined as: radiographic evidence of bone loss >2 mm, inflammation of the peri-implant mucosa as defined by positive BoP and/or suppuration, and at least one site with PD ≥ 5 mm.
- Based on the radiographic examination, the affected implant should not have a vertical peri-implant defect. Positive selection was based on the presence of pe-ri-implant lesions wider than 4 mm, with an angle greater than 35 º.
- In patients with a history of periodontitis, periodontal therapy should have been provided at least 6 months prior to the initiation of the study.
Exclusion Criteria:
- Presence of relevant medical conditions and/or systemic medications that would contraindicate the surgical procedure or modify the tissue response after therapy.
- Patients requiring antibiotic prophylaxis.
- Heavy smokers (> 10 cigarettes/day).
- Pregnant or lactating women
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Enkelt
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
---|---|
Eksperimentell: Glycine - Test
Polishing treatment with glycine powder air-polishing after ultrasonic plaque debridement.
|
Every 3 months, ultrasonic instrumentation was carried out with an specific implant tip coated with Polyether Ether Ketone (PEEK), activated subgingivally and circumferentially around the implant.
Then, the implants were treated with glycine powder air-polishing.
|
Aktiv komparator: Rubber cup - Control
Polishing treatment with a rubber cup and polishing paste after ultrasonic debridement
|
Every 3 months, ultrasonic instrumentation was carried out with an specific implant tip coated with Polyether Ether Ketone (PEEK), activated subgingivally and circumferentially around the implant.
Then, the implants were treated with rubber cup and a polishing paste.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Probing Pocket Depth
Tidsramme: Baseline, 6 and 18 months after the surgical procedure
|
Changes in Probing Pocket Depth measured in milimeters with a manual periodontal probe
|
Baseline, 6 and 18 months after the surgical procedure
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Distance of Gingival Recession
Tidsramme: Baseline, 6 and 18 months after the surgical procedure
|
Recession distance of the mucosal margin relative to the restoration margin (REC) at the implant (6 sites/implant) measured in milimeters with a manual periodontal probe
|
Baseline, 6 and 18 months after the surgical procedure
|
Bleeding on Probing index
Tidsramme: Baseline, 6 and 18 months after the surgical procedure
|
Rate of Presence / absence Bleeding on Probing at the implant (6 sites/implant)
|
Baseline, 6 and 18 months after the surgical procedure
|
Plaque Index
Tidsramme: Baseline, 6 and 18 months after the surgical procedure
|
Rate of Presence / absence of Plaque at the implant (6 sites/implant)
|
Baseline, 6 and 18 months after the surgical procedure
|
Suppuration Index
Tidsramme: Baseline, 6 and 18 months after the surgical procedure
|
Rate of Presence / absence of suppuration at the implant (6 sites/implant)
|
Baseline, 6 and 18 months after the surgical procedure
|
Radiographic bone loss distance measured from the prosthetic connection platform to the bottom of the intraosseous defect
Tidsramme: Baseline, 6 and 18 months after the surgical procedure
|
Intraoral standardised radiographs of the site of interest measured in digital intraoral radiographs using an image-processing software
|
Baseline, 6 and 18 months after the surgical procedure
|
Concentration of the selected cytokines measured in pg/ml (IL1B; Il-6; IL-8; Tumoral Necrosis Factor Alpha)
Tidsramme: Baseline, 6 and 18 months after the surgical procedure
|
Samples taken from the gingival crevicular fluid (GCF) were taken from each included implant from the deepest PD site with positive BoP, at baseline and at the final evaluation, always prior to microbiological sampling.
Samples were taken using the filter paper technique.
After isolation of the area with cotton rolls and gentle cleaning with air and a gauze to remove supragingival biofilm deposits and potential saliva contamination, a paper strip of standard length and height was inserted into the peri-implant pocket, until mild resistance was felt and left in place for 30 seconds.
The soaked volume of GCF was measured using the Periotron 8000® device.
Subsequently, the paper strips were inserted in micro-centrifuge plastic tubes and immediately stored at -80°C until further processing.
Analyses were carried out using a Luminex System (Luminex® 200, Luminex Corporation, Austin, TX, USA) to determine volume of the following biomarkers: IL-1β, IL-6, IL-8 and TNF-α.
|
Baseline, 6 and 18 months after the surgical procedure
|
Presence of putative periodontal pathogens
Tidsramme: Baseline, 6 and 18 months after the surgical procedure
|
Sample from the deepest site in the evaluated implant using two consecutive sterile paper-points kept in place for 10 seconds and then transferred into a screw-capped vial, containing 1.5 mL of reduced transport fluid (RTF).
Samples were transferred to the microbiological laboratory within 2 hours and homogenized by vortexing for 30 seconds and serially diluted in phosphate buffer saline (PBS).
Then, 0.1 mL of each dilution was plated manually on the specific medium Dentaid-1, for the detection of Aggregatibacter actinomycetemcomitans, and incubated for 3 days in air with 5% CO2 at 37ºC.
Samples were also plated into a non-selective blood agar plate, supplemented with haemine (5 mg/l), menadione (1 mg/l) and 5% sterile horse blood, with 7-14 days of anaerobic incubation.
|
Baseline, 6 and 18 months after the surgical procedure
|
Frequency of detection of putative periodontal pathogens
Tidsramme: Baseline, 6 and 18 months after the surgical procedure
|
Sample from the deepest site in the evaluated implant using two consecutive sterile paper-points kept in place for 10 seconds and then transferred into a screw-capped vial, containing 1.5 mL of reduced transport fluid (RTF).
Samples were transferred to the microbiological laboratory within 2 hours and homogenized by vortexing for 30 seconds and serially diluted in phosphate buffer saline (PBS).
Then, 0.1 mL of each dilution was plated manually on the specific medium Dentaid-1, for the detection of Aggregatibacter actinomycetemcomitans, and incubated for 3 days in air with 5% CO2 at 37ºC.
Samples were also plated into a non-selective blood agar plate, supplemented with haemine (5 mg/l), menadione (1 mg/l) and 5% sterile horse blood, with 7-14 days of anaerobic incubation.
|
Baseline, 6 and 18 months after the surgical procedure
|
Proportions of putative periodontal pathogens
Tidsramme: Baseline, 6 and 18 months after the surgical procedure
|
Sample from the deepest site in the evaluated implant using two consecutive sterile paper-points kept in place for 10 seconds and then transferred into a screw-capped vial, containing 1.5 mL of reduced transport fluid (RTF).
Samples were transferred to the microbiological laboratory within 2 hours and homogenized by vortexing for 30 seconds and serially diluted in phosphate buffer saline (PBS).
Then, 0.1 mL of each dilution was plated manually on the specific medium Dentaid-1, for the detection of Aggregatibacter actinomycetemcomitans, and incubated for 3 days in air with 5% CO2 at 37ºC.
Samples were also plated into a non-selective blood agar plate, supplemented with haemine (5 mg/l), menadione (1 mg/l) and 5% sterile horse blood, with 7-14 days of anaerobic incubation.
|
Baseline, 6 and 18 months after the surgical procedure
|
Counts of putative periodontal pathogens
Tidsramme: Baseline, 6 and 18 months after the surgical procedure
|
Sample from the deepest site in the evaluated implant using two consecutive sterile paper-points kept in place for 10 seconds and then transferred into a screw-capped vial, containing 1.5 mL of reduced transport fluid (RTF).
Samples were transferred to the microbiological laboratory within 2 hours and homogenized by vortexing for 30 seconds and serially diluted in phosphate buffer saline (PBS).
Then, 0.1 mL of each dilution was plated manually on the specific medium Dentaid-1, for the detection of Aggregatibacter actinomycetemcomitans, and incubated for 3 days in air with 5% CO2 at 37ºC.
Samples were also plated into a non-selective blood agar plate, supplemented with haemine (5 mg/l), menadione (1 mg/l) and 5% sterile horse blood, with 7-14 days of anaerobic incubation.
|
Baseline, 6 and 18 months after the surgical procedure
|
Samarbeidspartnere og etterforskere
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- EMS/MTO
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .
Kliniske studier på Peri-implantitt
-
Cynosure, Inc.FullførtPeri-orale rynker | Peri-orbitale rynkerForente stater
-
Ulthera, IncAvsluttetPeri-orale rynker | Peri-orbitale rynkerForente stater
-
University of ZagrebHar ikke rekruttert ennåPeri-implantat mukositt | Peri-implantitt og peri-implantat mukositt | Peri-implantat helse | Periimplantat sykdommer | Periimplantat beintap
-
Tuğba ŞAHİNFullførtPeri-implantitt, peri-implantat mukosittTyrkia
-
Proed, Torino, ItalyFullført
-
University of ManitobaUkjentPeri implantittCanada
-
PolyPid Ltd.MIS Implant Technologies, LtdFullført
-
Universitaire Ziekenhuizen KU LeuvenDentsply Sirona Implants and ConsumablesFullført
-
Ramón Pons CalabuigRekrutteringPeri-implantitt | Peri-implantat mukositt | Peri-implantat helseSpania
-
Hams Hamed AbdelrahmanFullført
Kliniske studier på Glycine air powder
-
University of Roma La SapienzaFullført
-
Massachusetts General HospitalFullførtPerinatal asfyksi | Asphyxia Neonatorum | Fødselsasfyksi
-
CIBA VISIONFullførtPresbyopi | Astigmatisme | Nærsynthet
-
ResMedFullførtSøvnapné, obstruktivForente stater
-
Right-AirUniversity of PennsylvaniaUkjentKronisk obstruktiv lungesykdom | KOLSForente stater
-
air up GmbHCitruslabsRekruttering
-
ResMedFullført
-
AlyatecFullførtEffekten av luftrensere hos astmatikere som er allergiske mot katt i ALYATEC miljøeksponeringskammerAstma | AllergiFrankrike
-
University of Medicine and Dentistry of New JerseyFullført
-
National Health and Medical Research Council, AustraliaDoris Duke Charitable Foundation; Cancer Council Tasmania; Duke Institute... og andre samarbeidspartnereFullført